In another attempt to allow the drug industry to pay the FDA to review broadcast TV DTC ads, the Bush administration is attempting to resurrect user fees.

“The proposed 2009 budget [Bush] sent to Congress this month calls for $14 million from fees to fund 27 FDA positions devoted to the consumer-ad-review program. In exchange, the FDA would review TV drug ads within 45 days of getting them from drugmakers — which is faster than many reviews occur now — and before the ads are seen by millions of viewers.” (See USA Today article here.)

In case you are trying to keep up with the on again/off again DTC user fee issue, check out these previous Pharma Marketing Blog posts (in reverse chronological order):